Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev. 2014;13(3):242–65.
Article
CAS
PubMed
Google Scholar
Gierthmuhlen J, Binder A, Baron R. Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol. 2014;10(9):518–28.
Article
PubMed
Google Scholar
Birklein F, Schlereth T. Complex regional pain syndrome-significant progress in understanding. Pain. 2015;156(Suppl 1):S94–103.
Article
PubMed
Google Scholar
Schwartzman RJ, Alexander GM, Grothusen JR. The use of ketamine in complex regional pain syndrome: possible mechanisms. Expert Rev Neurother. 2011;11(5):719–34.
Article
CAS
PubMed
Google Scholar
Dahan A, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain. 2011;15(3):258–67.
Article
CAS
PubMed
Google Scholar
Douglas SR, et al. Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome. J Pain. 2015;16(9):814–24.
Article
CAS
PubMed
Google Scholar
Bicknell AB. The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol. 2008;20(6):692–9.
Article
CAS
PubMed
Google Scholar
Solomon S. POMC-derived peptides and their biological action. Ann N Y Acad Sci. 1999;885:22–40.
Article
CAS
PubMed
Google Scholar
Smith AI, Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev. 1988;9(1):159–79.
Article
CAS
PubMed
Google Scholar
Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003;149(2):79–90.
Article
CAS
PubMed
Google Scholar
Stein C, et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA. 1990;87(15):5935–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Challis BG, et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci USA. 2004;101(13):4695–700.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coll AP, Loraine Tung YC. Pro-opiomelanocortin (POMC)-derived peptides and the regulation of energy homeostasis. Mol Cell Endocrinol. 2009;300(1–2):147–51.
Article
CAS
PubMed
Google Scholar
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lundblad JR, Roberts JL. Regulation of proopiomelanocortin gene expression in pituitary. Endocr Rev. 1988;9(1):135–58.
Article
CAS
PubMed
Google Scholar
Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci. 1999;885:312–28.
Article
CAS
PubMed
Google Scholar
Muller MB, et al. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation. Endocrinology. 2001;142(9):4150–3.
Article
CAS
PubMed
Google Scholar
Peterson SM, et al. Common features of microRNA target prediction tools. Front Genet. 2014;5:23.
Article
PubMed
PubMed Central
Google Scholar
Harden RN, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome. Pain. 2010;150(2):268–74.
Article
PubMed
PubMed Central
Google Scholar
Schwartzman RJ, et al. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009;147(1–3):107–15.
Article
CAS
PubMed
Google Scholar
Goldberg ME, et al. Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician. 2010;13(4):379–87.
PubMed
PubMed Central
Google Scholar
Klega A, et al. Central opioidergic neurotransmission in complex regional pain syndrome. Neurology. 2010;75(2):129–36.
Article
CAS
PubMed
Google Scholar
Takahashi M, et al. Lower beta-endorphin content of peripheral blood mononuclear cells in patients with complex regional pain syndrome. J Back Musculoskelet Rehabil. 2000;15(1):31–6.
CAS
PubMed
Google Scholar
Choi SE, et al. Elevated microRNA-34a in obesity reduces NAD + levels and SIRT1 activity by directly targeting NAMPT. Aging Cell. 2013;12(6):1062–72.
Article
CAS
PubMed
Google Scholar
Fu T, et al. Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor beta-Klotho. Proc Natl Acad Sci USA. 2012;109(40):16137–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Azari P, et al. Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review. CNS Drugs. 2012;26(3):215–28.
Article
CAS
PubMed
Google Scholar
Bruehl S. Complex regional pain syndrome. BMJ. 2015;351:h2730.
Article
PubMed
Google Scholar
Pritchard LE, Turnbull AV, White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol. 2002;172(3):411–21.
Article
CAS
PubMed
Google Scholar
Morton GJ, et al. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289–95.
Article
CAS
PubMed
Google Scholar
Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis. 2008;18(2):158–68.
Article
CAS
PubMed
Google Scholar
Blalock JE. Proopiomelanocortin and the immune-neuroendocrine connection. Ann N Y Acad Sci. 1999;885:161–72.
Article
CAS
PubMed
Google Scholar
Lyons PD, Blalock JE. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol. 1997;78(1):47–56.
Article
CAS
PubMed
Google Scholar
Lucas N, et al. Chronic delivery of alpha-melanocyte-stimulating hormone in rat hypothalamus using albumin-alginate microparticles: effects on food intake and body weight. Neuroscience. 2015;290:445–53.
Article
CAS
PubMed
Google Scholar
Starowicz K, Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 2003;73(7):823–47.
Article
CAS
PubMed
Google Scholar
Baltazi M, et al. Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Am J Cardiovasc Dis. 2011;1(1):48–59.
CAS
PubMed
PubMed Central
Google Scholar
Nam SY, et al. Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab. 2001;86(10):4849–53.
CAS
PubMed
Google Scholar
Hoggard N, et al. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf). 2004;61(1):31–9.
Article
CAS
Google Scholar
YaDeau JT, Morelli CM, Billingsley JK. Ketamine stimulates secretion of beta-endorphin from a mouse pituitary cell line. Reg Anesth Pain Med. 2003;28(1):12–6.
Article
CAS
PubMed
Google Scholar
Hirota K, Lambert DG. Ketamine: new uses for an old drug? Br J Anaesth. 2011;107(2):123–6.
Article
CAS
PubMed
Google Scholar
Adams ML, et al. The role of endogenous peptides in the action of opioid analgesics. Ann Emerg Med. 1986;15(9):1030–5.
Article
CAS
PubMed
Google Scholar
Gustin SM, et al. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain. 2010;151(1):69–76.
Article
CAS
PubMed
Google Scholar
Nikolarakis KE, Almeida OF, Herz A. Feedback inhibition of opioid peptide release in the hypothalamus of the rat. Neuroscience. 1987;23(1):143–8.
Article
CAS
PubMed
Google Scholar
Garcia de Yebenes E, Pelletier G. Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization. Neuropeptides. 1993;25(2):91–4.
Article
CAS
PubMed
Google Scholar
Jaffe SB, Sobieszczyk S, Wardlaw SL. Effect of opioid antagonism on beta-endorphin processing and proopiomelanocortin-peptide release in the hypothalamus. Brain Res. 1994;648(1):24–31.
Article
CAS
PubMed
Google Scholar
Wardlaw SL, Kim J, Sobieszczyk S. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Brain Res Mol Brain Res. 1996;41(1–2):140–7.
Article
CAS
PubMed
Google Scholar
Affolter HU, Reisine T. Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. J Biol Chem. 1985;260(29):15477–81.
CAS
PubMed
Google Scholar
Agelaki S, et al. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun. 2002;70(11):6068–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Webster EL, et al. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol. 2002;29(6):1252–61.
CAS
PubMed
Google Scholar
De Guire V, et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem. 2013;46(10–11):846–60.
Article
PubMed
Google Scholar